Organised by:
SPEAKERS
Local Speaker
A/Prof Toh Han Chong
Senior Consultant, Deputy Chief Executive (Strategic Partnerships)
National Cancer Centre Singapore
Dr Toh Han Chong is Deputy CEO (Strategic Partnerships), National Cancer Centre Singapore and Associate Professor at the Cancer & Stem Cell Biology Program and SingHealth-Duke Global Health Institute, Duke-NUS Medical School. His late mother was a primary care physician.
Dr Toh graduated from the University of London, UK, with an Intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, United Kingdom. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital and at the Massachusetts General Hospital, Harvard Medical School, Boston, USA. He then completed a research fellowship in cancer immunotherapy at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. He is an alumni of the Harvard Business School General Management Program.
Dr Toh received the National Outstanding Clinician Scientist Award 2018 for developing and building a solid tumour cancer immunotherapy programme in Singapore. His key interests are in gastrointestinal cancers, drug development, cancer immunology and immunotherapy and translational oncology.